Bristol Myers Squibb Co (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Bristol Myers Squibb Co achieved its new 52 week high price of $35.35 where it was opened at $35.20 down -0.20 points or -0.57% by closing at $35.09. BMY transacted shares during the day were over 9.07 million shares however it has an average volume of 10.48 million shares.

BMY has a market capitalization $59.46 billion and an enterprise value at $57.23 billion. Trailing twelve months price to sales ratio of the stock was 2.86 while price to book ratio in most recent quarter was 3.61. In profitability ratios, net profit margin in past twelve months appeared at 15.98% whereas operating profit margin for the same period at 33.04%.

Read Full Article and Disclaimer at:http://stockbling.com/8668/stock-highlights/bristol-myers-squibb-co-acco...